Omeros Corp (OMER)
3.075
0.00 (0.00%)
USD |
NASDAQ |
Apr 23, 16:00
3.075
0.00 (0.00%)
After-Hours: 20:00
Omeros Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2020 | 0.00 |
| September 30, 2020 | -15.21M |
| June 30, 2020 | -11.47M |
| March 31, 2020 | 1.757M |
| December 31, 2019 | -0.001M |
| September 30, 2019 | 100.40M |
| June 30, 2019 | 75.16M |
| March 31, 2019 | 50.06M |
| December 31, 2018 | 29.87M |
| September 30, 2018 | 21.61M |
| June 30, 2018 | 38.66M |
| March 31, 2018 | 54.16M |
| December 31, 2017 | 64.82M |
| September 30, 2017 | 63.97M |
| June 30, 2017 | 53.60M |
| March 31, 2017 | 46.46M |
| December 31, 2016 | 41.62M |
| September 30, 2016 | 35.39M |
| June 30, 2016 | 27.36M |
| March 31, 2016 | 20.54M |
| December 31, 2015 | 13.51M |
| September 30, 2015 | 7.014M |
| June 30, 2015 | 3.969M |
| March 31, 2015 | 0.827M |
| Date | Value |
|---|---|
| December 31, 2014 | 0.539M |
| September 30, 2014 | 0.528M |
| June 30, 2014 | 0.51M |
| March 31, 2014 | 0.605M |
| December 31, 2013 | 1.60M |
| September 30, 2013 | 3.014M |
| June 30, 2013 | 4.235M |
| March 31, 2013 | 5.621M |
| December 31, 2012 | 6.022M |
| September 30, 2012 | 5.582M |
| June 30, 2012 | 5.152M |
| March 31, 2012 | 4.781M |
| December 31, 2011 | 4.524M |
| September 30, 2011 | 4.357M |
| June 30, 2011 | 3.624M |
| March 31, 2011 | 2.966M |
| December 31, 2010 | 2.105M |
| September 30, 2010 | 1.563M |
| June 30, 2010 | 1.751M |
| March 31, 2010 | 1.625M |
| December 31, 2009 | 1.444M |
| September 30, 2009 | 1.191M |
| June 30, 2009 | 1.25M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
-15.21M
Minimum
Sep 2020
100.40M
Maximum
Sep 2019
21.52M
Average
--
Median
Dec 2020
Revenue (TTM) Benchmarks
| Aspira Womens Health Inc | 9.154M |
| Ardelyx Inc | 124.46M |
| Panbela Therapeutics Inc | -- |
| Ensysce Biosciences Inc | -- |
| MAIA Biotechnology Inc | -- |